Showing results (21-30 of 26) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Methods (San Diego, Calif.)|January 16, 2021
Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assaysYash Gupta, Dawid Maciorowski, Samantha E Zak, et al.Nature Communications|February 3, 2021
Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitorsJerzy Osipiuk, Saara-Anne Azizi, Steve Dvorkin, et al.Biorxiv : the Preprint Server for Biology|March 24, 2021
Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune ResponseLong Chi Nguyen, Dongbo Yang, Vlad Nicolaescu, et al.Biorxiv : the Preprint Server for Biology|September 10, 2020
Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 in vitroNir Drayman, Krysten A Jones, Saara-Anne Azizi, et al.Science Advances|January 20, 2022
Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responsesLong Chi Nguyen, Dongbo Yang, Vlad Nicolaescu, et al.Science (New York, N.Y.)|July 21, 2021
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2Nir Drayman, Jennifer K DeMarco, Krysten A Jones, et al.Pageof 3